# The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients

> **NCT05279937** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Tulane University** · enrollment: 40 (estimated)

## Conditions studied

- Ehlers-Danlos Syndrome
- Low Back Pain
- Sacroiliac Instability

## Interventions

- **DRUG:** Dextrose 50% Intravenous Solution
- **DRUG:** Lidocaine 1% Injectable Solution

## Key facts

- **NCT ID:** NCT05279937
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05279937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05279937, "The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05279937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*